LODDO, ROBERTA
 Distribuzione geografica
Continente #
EU - Europa 156.097
NA - Nord America 14.812
AS - Asia 5.256
SA - Sud America 785
Continente sconosciuto - Info sul continente non disponibili 525
AF - Africa 125
OC - Oceania 11
Totale 177.611
Nazione #
IT - Italia 153.111
US - Stati Uniti d'America 14.570
CN - Cina 1.885
SG - Singapore 1.834
UA - Ucraina 899
SE - Svezia 636
BR - Brasile 630
VN - Vietnam 418
DE - Germania 341
FI - Finlandia 298
GB - Regno Unito 289
FR - Francia 270
IN - India 260
HK - Hong Kong 196
CA - Canada 133
KR - Corea 127
BD - Bangladesh 93
IQ - Iraq 67
TR - Turchia 55
JP - Giappone 48
PK - Pakistan 46
AR - Argentina 45
MA - Marocco 43
NL - Olanda 39
RU - Federazione Russa 39
BE - Belgio 36
MX - Messico 35
EC - Ecuador 32
JO - Giordania 30
AT - Austria 28
ID - Indonesia 28
ES - Italia 24
SA - Arabia Saudita 24
VE - Venezuela 22
UZ - Uzbekistan 20
IR - Iran 19
PL - Polonia 19
ZA - Sudafrica 19
JM - Giamaica 17
PH - Filippine 17
EG - Egitto 16
TW - Taiwan 15
CL - Cile 12
CO - Colombia 12
HN - Honduras 11
LT - Lituania 11
PY - Paraguay 11
CR - Costa Rica 10
TN - Tunisia 10
IL - Israele 9
MY - Malesia 9
AE - Emirati Arabi Uniti 8
DZ - Algeria 8
UY - Uruguay 8
AU - Australia 7
PE - Perù 7
AZ - Azerbaigian 6
GT - Guatemala 6
KZ - Kazakistan 6
NG - Nigeria 6
DO - Repubblica Dominicana 5
IE - Irlanda 5
KE - Kenya 5
LV - Lettonia 5
NI - Nicaragua 5
OM - Oman 5
PA - Panama 5
SV - El Salvador 5
AL - Albania 4
BG - Bulgaria 4
BO - Bolivia 4
CH - Svizzera 4
ET - Etiopia 4
GE - Georgia 4
MU - Mauritius 4
SK - Slovacchia (Repubblica Slovacca) 4
CW - ???statistics.table.value.countryCode.CW??? 3
DK - Danimarca 3
HR - Croazia 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
PS - Palestinian Territory 3
RO - Romania 3
RS - Serbia 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
EE - Estonia 2
EU - Europa 2
GP - Guadalupe 2
GY - Guiana 2
LB - Libano 2
NP - Nepal 2
Totale 177.063
Città #
Cagliari 149.011
Uta 3.585
Ashburn 1.604
Fairfield 1.468
Woodbridge 1.217
Singapore 981
Houston 953
Chandler 883
San Jose 665
Ann Arbor 646
Dallas 610
Seattle 569
Wilmington 553
Jacksonville 514
Boardman 505
Cambridge 500
Nyköping 402
Beijing 360
Dearborn 302
Los Angeles 211
Council Bluffs 197
Santa Clara 166
Nanjing 162
Hong Kong 161
Helsinki 156
Hefei 148
Lauterbourg 148
Ho Chi Minh City 140
Shanghai 131
Boston 130
Buffalo 110
New York 110
Seoul 102
Columbus 77
The Dalles 75
Hanoi 73
São Paulo 72
San Diego 60
Shenyang 55
Pune 51
Guangzhou 45
Toronto 45
Milan 42
Jiaxing 41
Tianjin 41
Frankfurt am Main 40
Nanchang 40
Atlanta 39
Chicago 39
Hebei 39
Munich 37
Redwood City 37
Sassari 37
Tokyo 37
Dong Ket 34
Casablanca 33
Changsha 32
Mountain View 32
Brussels 31
London 30
Orem 25
Phoenix 25
Verona 24
Washington 24
Jinan 23
Amman 22
Kunming 22
Rome 22
Brooklyn 20
Nuremberg 20
Rio de Janeiro 20
Zhengzhou 20
Orange 19
Stockholm 19
Da Nang 18
Norwalk 18
San Francisco 18
Tashkent 18
Warsaw 18
Redondo Beach 17
Amsterdam 16
Manchester 16
Palermo 16
Bengaluru 15
Chennai 15
Denver 15
Guayaquil 15
Haiphong 15
Wuhan 15
Baghdad 14
Fuzhou 14
Ankara 13
Düsseldorf 13
Kingston 13
Montreal 13
Auburn Hills 12
Hangzhou 12
Jakarta 12
Mumbai 12
Ningbo 12
Totale 169.304
Nome #
Synthesis, structural characterization and biological evaluation of 4'-C-methyl- and phenyl-dioxolane pyrimidine and purine nucleosides 3.679
Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives 3.444
Synthesis and antiviral activity of new phenylimidazopyridines and N-benzylidenequinolinamines derived by molecular simplification of phenylimidazo[4,5-g]quinolines 3.017
Activity of bis(7-hydroxycoumarin) Mannich bases against bovine viral diarrhoea virus 2.933
Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5 2.892
Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents 2.694
N-((1,3-Diphenyl-1H-pyrazol-4-yl)methyl)anilines: A novel class of anti-RSV agents 2.674
Unconventional Knoevenagel-type indoles: Synthesis and cell-based studies for the identification of pro-apoptotic agents 2.674
Quinoxaline derivatives as new inhibitors of coxsackievirus B5 2.632
Dichloro-phenyl-benzotriazoles: a new selective class of human respiratory syncytial virus entry inhibitors 2.624
Benzimidazole derivatives endowed with potent antileishmanial activity 2.476
A combined in silico/in vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems 2.454
Synthesis of novel fluoro analogues of MKC442 as microbicides 2.433
Synthesis and biological evaluation of (acyl)hydrazones and thiosemicarbazones obtained via in situ condensation of iminium salts with nitrogen-containing nucleophiles. 2.433
Synthesis and anti-HIV-1 evaluation of some novel MC-1220 analogs as non-nucleoside reverse transcriptase inhibitors 2.432
1,2-benzisothiazol-3(2h)-one benzenesulfonamides targeting the hiv nucleocapsid proteins are potential microbicide candidates for the prevention of mucosal hiv transmission/acquisition 2.200
Antiviral activities of 5-chlorobenzotriazole derivatives 2.196
A Computationally-Based Explanation for the Knocking Out Activity of the Microbicide MC1220 2.128
Benzimidazole-based derivatives as privileged scaffold developed for the treatment of the RSV infection: a computational study exploring the potency and cytotoxicity profiles 2.113
Facile synthesis of the NNRTI microbicide MC-1220 and synthesis of its phosphoramidate prodrugs 2.110
3-Aryl-2-[1H-benzotriazol-1-yl]acrylonitriles: a novel class of potent tubulin inhibitors 2.098
Antiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-phenylbenzimidazole derivatives 2.071
Topical nonnucleoside reverse transcriptase inhibitor MC 1220 partially prevents vaginal RT-SHIV infection of macaques 2.066
Inhibitors of Yellow Fever Virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: Design, synthesis and antiviral evaluation. 2.007
Design, synthesis, antiviral evaluation, and SAR studies of new 1-(phenylsulfonyl)-1H-pyrazol -4-yl-methylaniline derivatives. 1.928
5,6-Dichloro-2-phenyl-benzotriazoles: New potent inhibitors of orthohantavirus 1.912
Synthesis and antiviral evaluation of 1-[(2-Phenoxyethyl)oxymethyl] and 6-(3,5-Dimethoxybenzyl) analogues of HIV drugs emivirine and TNK-651 1.911
Synthesis and biological evaluation of new 3-phenyl-1-[(4-arylpiperazin-1-yl)alkyl]-piperidine-2,6-diones 1.887
9-Aminoacridine-based agents impair the bovine viral diarrhea virus (BVDV) replication targeting the RNA-dependent RNA polymerase (RdRp) 1.809
Synthesis and evaluation of in vitro biological activity of 4-substituted arylpiperazine derivatives of 1,7,8,9-tetrachloro-10,10-dimethoxy-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione 1.770
Synergistic experimental/computational studies on arylazoenamine derivatives that target the bovine viral diarrhea virus RNA-dependent RNA polymerase 1.769
Preliminary anti-Coxsackie activity of novel 1-[4-(5,6-dimethyl(H)-1H(2H)-benzotriazol-1(2)-yl)phenyl]-3-alkyl(aryl)ureas 1.766
Styrylbenzimidazoles. Synthesis and biological activity - part 3 1.759
null 1.667
Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus 1.652
Further SAR studies on bicyclic basic merbarone analogues as potent antiproliferative agents 1.628
null 1.577
Results on different formulations of an NNRTI candidate (MC 1220) for application as topical microbicide 1.575
Antimicrobial activity of 10-(diphenylmethylene)-4-azatricyclo[5.2.1.0 2,6]dec-8-ene-3,5-dione derivatives 1.523
In vitro evaluation of the anti-HIV-1 activity of Liposomes and gel ingredients 1.508
2,3-dihydro-1,2-diphenyl-substituted 4H-pyridinone derivatives as new anti flaviviridae inhibitors 1.483
1,2-benzisothiazol-3(2H)-one benzenesulfonamides as new microbicide candidates for prevention of mucosal HIV infections 1.415
Synthesis and anti-HIV-1 activity of new fluoro-HEPT analogues: an investigation on fluoro versus hydroxy substituents 1.351
Syntheses and in vitro biologic screening 3 of 1-aryl-10H-[1,2,4]triazolo[30,40:3,4][1,2,4]triazino[5,6-b]indoles 1.284
Aryl nucleoside H-phosphonates. Part 15: Synthesis, properties and, anti-HIV activity of aryl nucleoside 50-a-hydroxyphosphonates 1.279
In vitro evaluation of the anti-HIV-1 activity of liposomes and gel ingredients 1.277
Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines. 1.239
Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives 1.236
A novel synthetic route for the anti-HIV drug MC-1220 and its analogues 1.192
Protective properties of non-nucleoside reverse transcriptase inhibitor (MC1220) incorporated into liposome against intravaginal challenge of Rhesus Macaques with RT-SHIV 1.164
Anti-BVDV activity evaluation of naphthoimidazole derivatives compared with parental imidazoquinoline compounds. 1.158
null 1.150
Platinum and palladium-triazole complexes as highly potential antitumor agents 1.139
Synthesis and in vitro anti-HIV activity of N-1,3-benzo[d]thiazol-2-yl-2-(2-oxo-2H-chromen-4-yl)acetamide derivatives using MTT method 1.139
Antiviral activity of benzotriazole based derivatives 1.119
null 1.096
Synthesis, in vitro antiproliferative and anti-HIV activity of new derivatives of 2-Piperazino-1,3-benzo[d]thiazoles 1.093
null 1.044
Inhibition of enterovirus a71 by a novel 2-phenyl-benzimidazole derivative 1.041
Potent flaviviridae inhibitors: targeted finger domain of RdRp. 1.029
In vitro evaluation of the anti-viral activity of Aryl and Heteroaryl-Azoenammines 1.026
null 1.022
Potent flaviviridae inhibitors: targeted finger domain of RdRp 1.019
null 1.009
null 994
Pharmacophore modeling, resistant mutant isolation, docking, and MM-PBSA analysis: Combined experimental/computer-assisted approaches to identify new inhibitors of the bovine viral diarrhea virus (BVDV) 957
Mystery unveiled: benzimidazole docks different domains in Flaviviridae 957
null 950
Data from a phase IIb clinical trial evaluating valopicitabine (NM283) combined with pegylated interferon in treatment-naïve hepatitis C patients 936
null 896
null 895
Mystery Unveiled: Benzimidazole docks in different domains of HCV and BVDV RdRp 878
Synthesis, Antitumor and Antiviral In Vitro Activities of New Benzotriazole-Dicarboxamide Derivatives 869
null 868
null 857
null 840
null 833
null 832
null 786
(Hetero)aroyl esters of 2-(N-phthalimido)ethanol and analogues: parallel synthesis, anti-HIV-1 activity and cytotoxicity 775
Hepatitis C: New therapeutic approaches 764
null 760
Hindered nucleoside analogs as inhibitors of HCV RNA-dependent RNA polymerase: evolving vistas 742
null 737
null 732
null 717
null 712
Biological evaluation of 10-(diphenylmethylene)-4-azatricyclo[5.2.1.02,6]dec-8-ene-3,5-dione derivatives 702
null 694
Benzimidazoles as potent non nucleosidic inhibitors of Respiratory Syncytial Virus 658
Benzimidazole-2-Phenyl-Carboxamides as Dual-Target Inhibitors of BVDV Entry and Replication 647
Synthesis and antiproliferative acticity of basic thioanalogues of merbarone 638
Synthesis and in vitro antiproliferative activity of new benzothiazole derivatives 621
Synthesis and in vitro antiviral studies of bis(pivaloyloxymethyl)ester derivative of 9-[((phosphonomethyl)aziridin-1-yl)methyl]adenine(PMAMA) and analogues 619
Erratum to: Syntheses and in vitro biological screening of 1-aryl-10 H-[1,2,4]triazolo[3′,4′:3,4][1,2,4]triazino[5,6-b]indoles 600
null 595
Synthesis and in vitro antiproliferative activity of new adamantylthiazolyl-1,3,4-oxadiazoles 587
null 581
Design, synthesis, and antiviral activities of new benzotriazole-based derivatives 568
Triazene derivatives endowed with antiproliferative and antiviral activities 568
Totale 143.490
Categoria #
all - tutte 244.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 244.889


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.981 0 0 0 653 814 756 501 459 1.008 822 971 997
2022/202313.159 1.260 1.425 1.335 995 1.155 1.352 723 857 981 1.015 1.377 684
2023/202417.171 624 965 938 1.330 1.794 2.593 2.665 1.248 762 1.046 1.645 1.561
2024/202528.017 6.778 7.458 3.279 2.949 1.577 1.734 2.647 213 378 271 326 407
2025/202610.178 576 453 1.172 821 777 798 1.707 1.111 792 1.034 645 292
2026/20272.267 116 467 744 940 0 0 0 0 0 0 0 0
Totale 177.611